About
Janine Schuurman is a scientist and biotech consultant with a PhD in Molecular Immunology from the University of Amsterdam. She spent over two decades at Genmab beginning in 2000, where she contributed to the development of six FDA/EMA-approved therapeutic antibodies and co-invented platform technologies including DuoBody®, HexaBody®, and HexElect®, which underpin multiple approved therapies. She currently operates an independent consulting practice and serves on the Board of Directors of The Antibody Society, having held the positions of Vice President and President from 2022 to 2025.
Experience
- Lust for Life Science B.V.Independent Biotech Consultantcurrent2023 — present
- Laigo BioScientific Advisory Board membercurrent2026 — present
- Cartography BiosciencesScientific Advisory Board membercurrent2023 — present
- Commit BiologicsMember Board of Directorscurrent2025 — present
- Commit BiologicsScientific Advisory Board member (chair)current2025 — present
- Commit BiologicsScientific Advisor2024 — 2025
- FairJourney BiologicsScientific Advisory Board member (chair)current2024 — present
- AbTherxScientific Advisorcurrent2024 — present
- Bioqube VenturesAdvisorcurrent2023 — present
- Oncode InstituteInvestment Advisory Committee membercurrent2021 — present
- The Antibody SocietyMember Board of Directorscurrent2020 — present
- The Antibody SocietyPresident2024 — 2025
- The Antibody SocietyVice President2022 — 2023
- GenmabSenior Vice President, Head Antibody Research & Technology2021 — 2023
- GenmabCorporate Vice President Antibody Research and Technology2018 — 2021The Netherlands
- GenmabVice President Research2014 — 2017Utrecht, Netherlands
- GenmabDirector Strategic Research2011 — 2013
- GenmabAssociate Director Research2000 — 2010
- Keystone Symposia on Molecular & Cellular BiologySAB member2019 — 2023
- Utrecht UniversityPostdoctoral Research Fellow1998 — 2000
Education
- University of AmsterdamDoctor of Philosophy - PhD, Immunology1992 — 1997
- University of AmsterdamMedical Biology1987 — 1992
Skills & more
Thought LeadershipCross-functional Team LeadershipAntibody EngineeringBiotechnology25Drug Development10Lifesciences16Monoclonal Antibodies17Life Sciences10Molecular Biology12Biopharmaceuticals8Immunology18Drug Discovery12
+7 more
Clinical DevelopmentAntibodiesTechnology TransferBiochemistryTherapeutic Antibody DiscoveryAntibody SciencePharmaceutical IndustryFrom Janine's professional profile.
Colleagues at Bioqube Ventures
Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Dirk Reyn
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures
Joris De Maeyer
Executive in Residence at Bioqube Ventures
Frequently asked questions
- Where does Janine Schuurman work?
- Janine Schuurman is Senior Advisor at Bioqube Ventures.
Same school
Also attended University of Amsterdam174
TorjusInvestor at InvestinorDamien van der BijlInvestment Director at Capricorn Venture PartnersAndrea van ElsasInvestor at Third Rock VenturesFreya WordsworthAssociate at Nauta CapitalEmil SchaeferInvestor at Index VenturesDjoni de VosPrincipal at Keen Venture Partners
+ 168 more
Shared employers
Also worked at Oncode Institute4
Also worked at Genmab3
Also worked at Keystone Symposia on Molecular & Cellular Biology2
Also worked at Utrecht University19
Erik MeijerVenture Scout at Storm VenturesLaura LentzExecutive Assistant at Castle Island VenturesPim SwartAssociate Partner at Maven 11Tea EleziGeneral Partner at PeakRené KuijtenPartner, Head of EQT Life Sciences at EQT Life SciencesDiede BrunenPrincipal at BioGeneration Ventures
+ 13 more